An explorative analysis of ERCC1-19q13 copy number aberrations in a chemonaive stage III colorectal cancer cohort

BACKGROUND: Platinum-based chemotherapy has long been used in the treatment of a variety of cancers and functions by inducing DNA damage. ERCC1 and ERCC4 are involved in the removal of this damage and have previously been implicated in resistance to platinum compounds. The aim of the current investi...

Descripción completa

Detalles Bibliográficos
Autores principales: Smith, David Hersi, Christensen, Ib Jarle, Jensen, Niels Frank, Markussen, Bo, Müller, Sven, Nielsen, Hans Jørgen, Brünner, Nils, Nielsen, Kirsten Vang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4015772/
https://www.ncbi.nlm.nih.gov/pubmed/24144331
http://dx.doi.org/10.1186/1471-2407-13-489

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4015772/
https://www.ncbi.nlm.nih.gov/pubmed/24144331
http://dx.doi.org/10.1186/1471-2407-13-489

Ejemplares similares